Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
actuarial, administered, alia, bill, binding, burden, Carolina, category, Committee, confusingly, Cyclosporine, Dermavita, Dima, Dimitri, discrete, documentation, domain, dry, duration, ease, Emulsion, enhancing, erosion, EU, Fabre, Fallon, fetzima, flat, France, French, front, FZE, Goldberg, ground, House, Huahai, immunity, inventorship, Jacqueline, judgement, judicial, KBC, Lyndra, MDNC, Media, Medicament, metric, Mexico, misuse, Mitchel, Mohawk, moot, MSN, Nanterre, national, nonfinancial, North, outlook, Oversight, parallel, Pierre, postponed, preliminarily, Prinston, provisional, pte, quantity, reassigned, recovery, refine, refining, Reform, regional, revoke, SA, Saint, SAS, sham, Sillam, Simapharm, Solco, sovereign, teleconference, Teoxane, Torrent, tribal, Tribe, virtually, Vralyar, XC, Zhejiang
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view